Automating Delirium Severity in the ICU

Recruiting Observational Study
Intensive Care Unit Delirium Encephalopathy Delirium
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
Mayo Clinic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients \>50 years of age. The main questions it aims to answer are: * Is the trained convolutional neural network able to reliably measure delirium severity. * Is the Passive Digital Marker able to accurate…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: • Age \>50; * Estimated length of stay \>24 hours in ICU; and * Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal. Exclusion Criteria: * Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdra…
Contacts

Heidi Lindroth, PH.D. R.N.

507-284-3662

lindroth.heidi@mayo.edu

CONTACT

Hannah Friesen

1-507-284-2197

friesen.hannah@mayo.edu

CONTACT